Advertisement

Topics

Novus Biologicals, Inc Company Profile

01:52 EDT 25th September 2018 | BioPortfolio

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological research community with a mechanism for commercializing unique biological materials and to monitor scientific trends and supply materials to serve these trends. We now offer over 10,000 antibodies to serve a diverse array of research.

Location

8100 Southpark Way A-8
Littleton
Colorado
80160
United States of America

Contact

Phone: 303.730.1950
Fax: 303.730.1966
Email: karen@novusbio.com


News Articles [72 Associated News Articles listed on BioPortfolio]

In The Spotlight: Novus Therapeutics

Shares of Novus Therapeutics (NVUS) are up an impressive 47% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is up a mere 3% for the same period.

Novus Therapeutics Reports First Quarter 2018 Financial Results

IRVINE, Calif.–(BUSINESS WIRE)–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and ...

Boeing, Novus Aviation Announce Commitment For Up To Four 777-300ERs

CHICAGO (dpa-AFX) - Boeing (BA) and Dubai-based aircraft lessor, Novus Aviation Capital, announced its first direct agreement with Boeing for up to four 777-300ERs (Extended Range) at the 2018 Far...

FDA approach to retrospectively naming biologicals

How the US Food and Drug Administration’s (FDA) is tackling retrospective naming of biologicals was an issue covered by Dr Kellie Taylor, Associate Director of the Office of Medication Error Prevent...

TGA proposes changes to biologicals regulations

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA) announced on 20 April 2018 the release of proposed amendments to its biologicals regulations that are set to take effec...

FDA issues guidance for labelling biologicals and biosimilars

The US Food and Drug Administration (FDA) has issued two new guidance documents that provide recommendations to industry on labelling requirements for biologicals and biosimilars.

Regulation of biologicals in Colombia

Since the introduction of Decree 1782 Colombia has been moving towards a new regulatory landscape for biologicals (productos bioterapéuticos) and similar biotherapeutic products (productos bioterape...

WuXi Biologics expands its biologicals manufacturing facilities

China-based WuXi Biologics, headquartered in Wuxi city of Jiangsu Province, is expanding its biologicals manufacturing capacity with new facilities planned in Ireland, China, Singapore and the US.

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 20%

Human albumin grifols [Instituto Grifols, S.A.]

Albumin (Human) U.S.P. Human Albumin Grifols 25%

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

The analgesic potential of cytokine neutralization with biologicals.

Many acute and chronic inflammatory diseases, cancer and neuropathic disorders are accompanied by severe pain states reducing drastically the life quality of the patients. Biologicals which preferenti...

A large single hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents.

Large-scale studies of Drug Provocation Testing (DPT) or Rapid Drug Desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions OBJECTIVE...

Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

Biologicals targeting the interleukin (IL)-1β or IL-6 pathway are becoming prime choices for the treatment of children with systemic juvenile idiopathic arthritis (sJIA). Up to 1 in 3 sJIA children r...

Significant Drying Time Reduction using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.

Microwave-assisted freeze-drying is a rapid drying process well-known in food technology. However, little is known about its application to biologicals. In this study, we investigated the applicabilit...

History and perspectives on how to ensure antivenom accessibility in the most remote areas in Brazil.

A plan to achieve self-sufficiency in manufacturing biologicals for public health has been structured for the last 40 years in Brazil, in the context of a reform in the health system. Industrial plant...

Clinical Trials [273 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine co-administered with GSK Biologicals' 10-valent pneumococcal conjugate (GSK1024850A) vaccine ...

Companies [58 Associated Companies listed on BioPortfolio]

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

NOVUS INTERNATIONAL

Novus International, Inc., a global leader in the animal agriculture industry, is a privately held corporation headquartered in St. Louis, Missouri. Formed as a joint venture in 1991, the Novus corpor...

Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in more than 90 countries around the world. An industry leader in anima...

Novus Therapeutics, Inc.

Novus Therapeutics is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (ENT). Novus has two technologies, each that has...

More Information about "Novus Biologicals, Inc" on BioPortfolio

We have published hundreds of Novus Biologicals, Inc news stories on BioPortfolio along with dozens of Novus Biologicals, Inc Clinical Trials and PubMed Articles about Novus Biologicals, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novus Biologicals, Inc Companies in our database. You can also find out about relevant Novus Biologicals, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record